Search

everythinglearnresearchcommunity

for

Search:↓

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Fasting may reduce chemotherapy side effects.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

HIV can cause unusual and severe skin problems that are hard to treat.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.